Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist

By Seiffert Dietmar   Thomas Beth E.   Bradley Jodi D.   Munzer Deborah A.   Tchinnes Maureen A.   Kornhauser David M.   Cain Valerie A.   Hua Tsuhung A.   Feuerstein Giora Z.   Martin David E.   Stern Andrew M.  

Platelets, Vol. 14, Iss. 3, 2003-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Effects of glycoprotein IIb/IIIa antagonists on platelet activation: development of a transfer method to mimic peak to trough receptor occupancy

By Billheimer J.T.   He B.   Spitz S.M.   Stern A.M.   Seiffert D.  

Thrombosis Research, Vol. 107, Iss. 6, 2002-09 ,pp. : 303-317

Elsevier

Access to resources Recommend Favorite

Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists

By Sirotkina Olga   Khaspekova Svetlana   Zabotina Anna   Shimanova Yulia   Mazurov Alexey  

Platelets, Vol. 18, Iss. 7, 2007-11 ,pp. : 506-514

Informa Healthcare

Access to resources Recommend Favorite

Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 3, 2004-07 ,pp. : 187-196

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Blockade in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 11, Iss. 4, 2001-05 ,pp. : 287-293

Karger

Access to resources Recommend Favorite